Innovarus

Innovarus is a UK pharmaceutical company developing long-acting injectable drug formulations for people with rare and chronic conditions. Its drug-delivery platform is designed to release medication over an extended period, potentially reducing the frequency of injections and clinic visits. The company is initially focused on therapeutic areas including acromegaly, neuroendocrine tumours and polycystic liver disease. Its laboratory is based at Alderley Park, with a Manchester office and research links to the University of Manchester.